Erik Harris - Insider Trading & Ownership

Entity
Individual
Location
60 Leveroni Court, Novato, California
Summary
The estimated net worth of Erik Harris is at least $3.96 M dollars as of June 4, 2024. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $3.61 M. Erik Harris is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $348 K.
All Insider Reports
All Insider Reports

Ownership of Erik Harris

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RARE Ultragenyx Pharmaceutical Inc. EVP & Chief Commercial Officer $3.61 M -$484 K -11.8% Mar 1, 2024
DNLI Denali Therapeutics Inc. Director $348 K May 31, 2024

Insider Transactions Reported by Erik Harris:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership